Galliprant — FDA Animal & Veterinary Adverse Event (ADE) Reports
Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Galliprant is a active ingredient.
Total reports
Galliprant: 984
Reports by species (top entries)
- Dog 984
Top reported reactions (VEDDRA terms, top entries)
- Death by euthanasia 150
- Lethargy (see also Central nervous system depression in Neurological) 150
- Diarrhoea 94
- Vomiting 85
- Seizure NOS 80
- Ataxia 79
- Lack of efficacy - NOS 78
- Urinary incontinence 74
- Limb weakness 67
- Anorexia 65
Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b14.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).